|
HLCS expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.562300E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.941400E-03 |
| Normal-vs-Stage2 |
3.616400E-01 |
| Normal-vs-Stage3 |
8.432200E-02 |
| Normal-vs-Stage4 |
1.641040E-01 |
| Stage1-vs-Stage2 |
6.362600E-01 |
| Stage1-vs-Stage3 |
9.804000E-01 |
| Stage1-vs-Stage4 |
6.449600E-01 |
| Stage2-vs-Stage3 |
6.920600E-01 |
| Stage2-vs-Stage4 |
4.978200E-01 |
| Stage3-vs-Stage4 |
6.466200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.207200E-04 |
| Normal-vs-AfricanAmerican |
2.561400E-01 |
| Normal-vs-Asian |
8.052000E-02 |
| Caucasian-vs-AfricanAmerican |
2.074200E-01 |
| Caucasian-vs-Asian |
9.931000E-01 |
| AfricanAmerican-vs-Asian |
6.678200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.34479999999815E-05 |
| Normal-vs-Female |
6.243400E-01 |
| Male-vs-Female |
4.760100E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.914010E-01 |
| Normal-vs-Extreme_Weight |
1.87972999999841E-05 |
| Normal-vs-Obese |
5.263800E-01 |
| Normal-vs-Extreme_Obese |
2.209600E-04 |
| Normal_Weight-vs-Extreme_Weight |
1.399390E-01 |
| Normal_Weight-vs-Obese |
4.856800E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.992000E-02 |
| Extreme_Weight-vs-Obese |
7.263700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
6.235000E-01 |
| Obese-vs-Extreme_Obese |
9.379900E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.945800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.400640E-01 |
| Normal-vs-Age(61-80Yrs) |
3.588000E-04 |
| Normal-vs-Age(81-100Yrs) |
6.20150000000264E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.822400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.526400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.250400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.433600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.983600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.241800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.540700E-03 |
| Normal-VS-Type2 PRCC |
1.676390E-02 |
| Normal-VS-KIRP CIMP |
8.335000E-01 |
| Normal-VS-Unclassified PRCC |
9.043600E-02 |
| Type1 PRCC-VS-Type2 PRCC |
7.710600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.717440E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.629200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.299400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.617000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.607000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.429900E-04 |
| Normal-vs-N1 |
1.404220E-01 |
| Normal-vs-N2 |
4.646400E-01 |
| N0-vs-N1 |
2.392200E-01 |
| N0-vs-N2 |
9.950600E-01 |
| N1-vs-N2 |
6.421200E-01 |
|
|
